Compound Summary
Compound Name: | 			Acecainide hydrochloride | 
Compound CID: | 			71417 | 
Synonyms: | 			Acecainide hydrochloride 34118-92-8 N-ACETYLPROCAINAMIDE HYDROCHLORIDE Acecainide HCl NAPA More... | 
Iupac Name: | 			4-acetamido-N-[2-(diethylamino)ethyl]benzamide;hydrochloride | 
InChI: | 					InChI=1S/C15H23N3O2.ClH/c1-4-18(5-2)11-10-16-15(20)13-6-8-14(9-7-13)17-12(3)19;/h6-9H,4-5,10-11H2,1-3H3,(H,16,20)(H,17,19);1H | 
InChIKey: | 				IYEWBJUCJHKLHD-UHFFFAOYSA-N | 
Canonical Smiles: | 		CCN(CC)CCNC(=O)C1=CC=C(C=C1)NC(=O)C.Cl | 
Isomeric Smiles: | 			CCN(CC)CCNC(=O)C1=CC=C(C=C1)NC(=O)C.Cl | 
Molecular Weight: | 		313.82 | 
Molecular Formula: | 			C15H24ClN3O2 | 
Molecular Weight: | 		313.82 | 
Molecular Formula: | 			C15H24ClN3O2 | 
Hydrogen Bond Donor Count: | 			3 | 
Hydrogen Bond Acceptor Count: | 			3 | 
Rotatable Bond Count: | 			7 | 
Heavy Atom Count: | 					21 | 
Complexity: | 				308 | 
| Acecainide hydrochloride | Acecainide hydrochloride | 
|---|---|
Acecainide hydrochloride | 			
34118-92-8 | 
N-ACETYLPROCAINAMIDE HYDROCHLORIDE | 			
Acecainide HCl | 
NAPA | 			
UNII-B9K738KX14 | 
4-acetamido-N-(2-(diethylamino)ethyl)benzamide hydrochloride | 			
ASL 601 | 
ASL-601 | 			
34118-92-8 (HCl) | 
MLS000863278 | 			
Acecainide hydrochloride USAN | 
ASL601;Acecainide hydrochloride | 			
4-((2-(Diethylamino)ethyl)carbamoyl)acetanilide monohydrochloride | 
B9K738KX14 | 			
N-Acetylprocainamide (hydrochloride) | 
NCGC00093534-02 | 			
DSSTox_CID_25748 | 
DSSTox_RID_81092 | 			
DSSTox_GSID_45748 | 
Acecainide hydrochloride (USAN) | 			
SMR000059132 | 
CAS-34118-92-8 | 			
SR-01000000030 | 
EINECS 251-831-2 | 			
Opera_ID_64 | 
ASL 601(Acecainide) | 			
MLS000028843 | 
MLS001148141 | 			
SCHEMBL122991 | 
SPECTRUM2300154 | 			
CHEMBL1256805 | 
DTXSID1045748 | 			
N-Acetylnovocainamide hydrochloride | 
Pharmakon1600-02300154 | 			
BCP20733 | 
Tox21_111206 | 			
Tox21_500009 | 
MFCD00012501 | 			
NSC759312 | 
AKOS015888341 | 			
Tox21_111206_1 | 
CCG-213649 | 			
LP00009 | 
NSC 759312 | 			
NSC-759312 | 
N-Acetylprocainamide hydrochloride, 99% | 			
NCGC00015072-10 | 
NCGC00093534-01 | 			
NCGC00093534-03 | 
NCGC00260694-01 | 			
AS-75674 | 
DB-048569 | 			
EU-0100009 | 
FT-0639157 | 			
A 5909 | 
A20512 | 			
D02746 | 
N16908 | 			
4-acetamido-N-(2-(diethylamino)ethyl)benzamide HCl | 
J-019456 | 			
SR-01000000030-2 | 
Acedainide; N-Acetylnovocainamide hydrochloride; NAPA | 			
Q27274550 | 
N-Acetylprocainamide hydrochloride, >=99% (HPLC), powder | 			
4-acetamido-N-2-(diethylamino)ethylbenzamide;hydrochloride | 
Benzamide, 4-(acetylamino)-N-(2-(diethylamino)ethyl)-, monohydrochloride | 			
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 2.000000000000000 | NS | N2 | 24134630 | Inactive | 
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point | 
|---|---|---|---|---|
| Caenorhabditis elegans | 2.000000000000000 | 1 | 1 |